Insider · CIK 0001990267
Heikki Lanckriet
Files at BFRI (Biofrontera Inc.). First filing -, latest -.
In brief
Heikki Lanckriet files SEC Form 4 as director at BFRI (Biofrontera Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Heikki Lanckriet has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | BFRI Biofrontera Inc. | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Mar 6, 2026 |
| Jul 22, 2025 | BFRI Biofrontera Inc. | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Sep 16, 2025 |
Questions about Heikki Lanckriet
Answered from the filings on this page, as of the latest one.
Is Heikki Lanckriet buying or selling?
Heikki Lanckriet has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Heikki Lanckriet's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Heikki Lanckriet has 0.
Where does Heikki Lanckriet file Form 4?
Heikki Lanckriet has filed Form 4 at BFRI (Biofrontera Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.